β¨ Medicines Distribution Consents
19 OCTOBER
NEW ZEALAND GAZETTE
3737
This consent is given subject to the following conditions:
(i) The medicine may only be prescribed by:
(a) Medical practitioners who are vocationally registered under the Medical Practitioners Act 1995 in the branches of psychological medicine or psychiatry; and
(b) Medical practitioners employed as registrars in psychological medicine or psychiatry who are under the supervision of persons of the kind referred to in paragraph (a) above.
(ii) Persons prescribing the medicine must comply with the requirements of the New Zealand Guidelines for the Use of Atypical Anti-Psychotic Drugs (2nd Edition September 1998) and the requirements of local hospital and health service protocols for the use of clozapine.
Dated this 11th day of October 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go7687
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Auralgan Ear Drops
Active Ingredient(s): Benzocaine 14mg/mL
Phenazone 54mg/mL
Dosage Form: Ear drops
New Zealand Sponsor: Whitehall Consumer Healthcare (NZ) Limited
Manufacturer(s): Interphil Laboratories Inc, Pittland, Cabuyao, Laguna, Philippines
Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia
Product: Buspirex
Active Ingredient(s): Buspirone hydrochloride 10mg
Dosage Form: Tablet
New Zealand Sponsor: Technilab Inc
Manufacturer(s): Technilab (Canada) Inc, Mirabel, Quebec, Canada
Product: Neurontin
Active Ingredient(s): Gabapentin 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Parke Davis (Div. Warner Lambert NZ Limited)
Manufacturer(s): Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Product: Neurontin
Active Ingredient(s): Gabapentin 800mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Parke Davis (Div. Warner Lambert NZ Limited)
Manufacturer(s): Warner-Lambert Inc, Vega Baja, Puerto Rico
Product: Roferon-A
Active Ingredient(s): Interferon alpha-2a 30MIU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer(s): F Hoffmann-La Roche AG, Basle, Switzerland
Product: Tramal Retard
Active Ingredient(s): Tramadol hydrochloride 100mg
Dosage Form: Modified release tablet
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Grunenthal GmbH, Stolberg, Germany
Product: Tramal Retard
Active Ingredient(s): Tramadol hydrochloride 150mg
Dosage Form: Modified release tablet
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Grunenthal GmbH, Stolberg, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2000, No 142
Gazette.govt.nz —
NZ Gazette 2000, No 142
β¨ LLM interpretation of page content
π₯
Provisional Consent to Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare11 October 2000
Medicines, Approval, Distribution, Health, Conditions, Prescription
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Approval, Distribution, Health, Pharmaceuticals